Table 2.
Age | ||
---|---|---|
Mean age at onset (range) | 39.95 years (16–61) | |
Mean age at attendance (range) | 44.69 years (24–65) | |
Symptom duration (range) | 4.74 years (0.3–21) |
N | Percentage of sample (%) | |
---|---|---|
Sex | ||
Male | 8 | 16 |
Female | 42 | 84 |
Predominant symptoms | ||
Weaknessa | 32 | 64 |
Left lower limb weakness | 26 | 52 |
Right lower limb weakness | 14 | 28 |
Left upper limb weakness | 22 | 44 |
Right upper limb weakness | 10 | 20 |
Functional seizures | 18 | 36 |
Other motor symptomsb | 29 | 58 |
Other sensory symptomsc | 22 | 44 |
Additional symptoms | ||
Fatigue | 31 | 62 |
Persistent pain | 32 | 64 |
Headaches | 13 | 26 |
Dizziness | 7 | 14 |
Dissociative episodes | 7 | 14 |
Cognitive difficulties | 18 | 36 |
Speech difficulties | 9 | 18 |
Falls | 13 | 26 |
Tremors | 11 | 22 |
Balance difficulties | 12 | 24 |
aIncludes bilateral upper and lower limb weakness
bIncludes involuntary movements, dystonia, tremors, and balance problems
cIncludes visual symptoms, dizziness, and tingling